Xanthine scaffold: scope and potential in drug development

被引：98

作者：

Singh, Nivedita ^{[1
]}

Shreshtha, Ashwinee Kumar ^{[2
]}

Thakur, M. S. ^{[3
]}

Patra, Sanjukta ^{[1
]}

机构：

[1] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati 781039, India

[2] Kathmandu Univ, Dhulikhel, Nepal

[3] Cent Food Technol Res Inst, Fermentat Technol & Bioengn Dept, Mysore, Karnataka, India

来源：

HELIYON | 2018年 / 4卷 / 10期

关键词：

Pharmaceutical chemistry; Natural product chemistry;

D O I：

10.1016/j.heliyon.2018.e00829

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Medicinal plants have been the basis for discovery of various important marketed drugs. Xanthine is one such lead molecule. Xanthines in various forms (caffeine, theophylline, theobromine, etc) are abode in tea, coffee, cocoa, chocolate etc. giving them popular recognition. These compounds are best known for their diverse pharmaceutical applications as cyclic nucleotide phosphodiesterase inhibition, antagonization of adenosine receptor, anti-inflammatory, anti-microbial, anti-oxidant and anti-tumor activities. These properties incentivize to use xanthine as scaffold to develop new derivatives. Chemical synthesis contributes greater diversity in xanthine based derivatisation. With highlighting the existing challenges in chemical synthesis, the present review focuses the probable solution to fill existing lacuna. The review summarizes the available knowledge of xanthine based drugs development along with exploring new xanthine led chemical synthesis path for bringing diversification in xanthine based research. The main objective of this review is to explore the immense potential of xanthine as scaffold in drug development.

引用

页数：38

共 175 条

[1]

AHN HS, 1989, BIOCHEM PHARMACOL, V38, P3331

[2]

Al-Azzawii KM., 2012, INT RES J PHARM, V3, P83

[3] Synthesis, Transformations, and Physicochemical Properties of 3-(4′-Methylphenyl)-8-Methylxanthine Derivatives [J].

Aleksandrova, E. V. ;

Levich, S. V. ;

Romanenko, N. I. ;

Shkoda, A. S. ;

Mikhal'chenko, E. K. .

CHEMISTRY OF NATURAL COMPOUNDS, 2014, 49 (06) :1105-1109

[4]

Aleksandrova K., 2014, OXIDANTS ANTIOXIDANT, V3, P187, DOI [10.5455/oams.191214.or.078, DOI 10.5455/OAMS.191214.OR.078]

[5] Direct conversion of theophylline to 3-methylxanthine by metabolically engineered E-coli [J].

Algharrawi, Khalid H. R. ;

Summers, Ryan M. ;

Gopishetty, Sridhar ;

Subramanian, Mani .

MICROBIAL CELL FACTORIES, 2015, 14

[6] Efficient synthesis of 1,3,7-substituted xanthines by a safety-catch protection strategy [J].

Allwood, Matthew B. ;

Cannan, Boorna ;

van Aalten, Daan M. F. ;

Eggleston, Ian M. .

TETRAHEDRON, 2007, 63 (50) :12294-12302

[7] Alkaloids as drug leads - A predictive structural and biodiversity-based analysis [J].

Amirkia, Vafa ;

Heinrich, Michael .

PHYTOCHEMISTRY LETTERS, 2014, 10 :XLVIII-liii

[8] Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain [J].

Andreeva, SG ;

Dikkes, P ;

Epstein, PM ;

Rosenberg, PA .

JOURNAL OF NEUROSCIENCE, 2001, 21 (22) :9068-9076

[9]

Andrei K., 2011, SOLUBILITY PHYS STAB

[10] MICROBIAL-PRODUCTION OF THEOBROMINE FROM CAFFEINE [J].

ASANO, Y ;

KOMEDA, T ;

YAMADA, H .

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1993, 57 (08) :1286-1289

← 1 2 3 4 5 6 7 8 9 10 →